This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Cancer Reconstruction of Head & Neck  • Neoplasms of Head & Neck  • Radiology of Head & Neck  • Radiation Therapy  • Computed Tomography  • Alert me on articles by topic  Social Bookmarking   What's this?

Rubén A. Velázquez, MD, PhD; H. Stan McGuff, DDS; David Sycamore, BS; Frank R. Miller, MD

Arch Otolaryngol Head Neck Surg. 2004;130:74-77.

Objective  To determine the sensitivity and specificity of computed tomographic (CT) scanning in predicting residual cervical metastatic disease (N-positive neck) in patients undergoing curative radiotherapy and chemoradiotherapy for squamous cell carcinoma (SCC) of the upper aerodigestive tract.

Design  Retrospective case series (1995-2002) of patients undergoing radiotherapy and chemoradiotherapy for advanced head and neck SCC.

Methods  Study entry criteria included N-positive neck disease, a complete response to treatment at the primary tumor site, posttreatment CT scan, posttreatment neck dissection, and correlation of posttreatment CT scan with pathologic neck specimen. We calculated the sensitivity and specificity of the CT scan to predict the presence of residual cervical metastatic disease after curative radiotherapy and chemoradiotherapy.

Results  Forty-three patients (including 10 with bilateral N-positive necks) met the study criteria for analysis. Twenty (38%) of the 53 neck dissection specimens were positive for residual cervical metastatic disease. The sensitivity of the CT scan was 85%, while the specificity was only 24%. The positive predictive value of the CT scan was 40%.

Conclusions  While the role of the posttreatment neck dissection remains controversial, the surgeon must rely on clinical examination and imaging studies. Our practice has been to perform planned staged neck dissections on all N2/N3 necks as well as N1 necks with an incomplete response to treatment. Based on our results, it appears that the CT scan technique lacks adequate sensitivity and specificity to reliably predict the presence of residual metastatic disease.

From the University of Texas Health Science Center at San Antonio, Department of Otolaryngology–Head and Neck Surgery, San Antonio. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective Risk-Adjusted [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography Assessment of Radiation Response in Head and Neck Cancer
Moeller et al.
JCO 2009;27:2509-2515.
ABSTRACT | FULL TEXT  

PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
Schoder et al.
JNM 2009;50:74S-88S.
ABSTRACT | FULL TEXT  

Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer
Ong et al.
JNM 2008;49:532-540.
ABSTRACT | FULL TEXT  

Effectiveness of Superselective and Selective Neck Dissection for Advanced Nodal Metastases After Chemoradiation
Robbins et al.
Arch Otolaryngol Head Neck Surg 2005;131:965-969.
ABSTRACT | FULL TEXT  

Management of Cervical Metastases in Advanced Squamous Cell Carcinoma of the Tonsillar Fossa Following Radiotherapy
Mau et al.
Arch Otolaryngol Head Neck Surg 2005;131:600-604.
ABSTRACT | FULL TEXT